Transcription factor 4 expression in the developing non-human primate brain: a comparative analysis with the mouse brain

Front Neuroanat. 2024 Oct 22:18:1478689. doi: 10.3389/fnana.2024.1478689. eCollection 2024.

Abstract

Transcription factor 4 (TCF4) has been implicated in a range of neuropsychiatric disorders, including major depressive disorder, bipolar disorder, and schizophrenia. Mutations or deletions in TCF4 cause Pitt-Hopkins syndrome (PTHS), a rare neurodevelopmental disorder. A detailed understanding of its spatial expression across the developing brain is necessary for comprehending TCF4 biology and, by extension, to develop effective treatments for TCF4-associated disorders. However, most current knowledge is derived from mouse models, which are invaluable for preclinical studies but may not fully capture the complexities of human neuropsychiatric phenotypes. This study compared TCF4 expression in the developing mouse brain to its regional and cellular expression patterns in normal prenatal, neonatal, and young adult rhesus macaque brains, a species more relevant to human neurodevelopment. While the general developmental expression of TCF4 is largely conserved between macaques and mice, we saw several interspecies differences. Most notably, a distinct layered pattern of TCF4 expression was clear in the developing macaque neocortex but largely absent in the mouse brain. High TCF4 expression was seen in the inner dentate gyrus of adult mice but not in macaques. Conversely, TCF4 expression was higher in the adult macaque striatum compared to the mouse striatum. Further research is needed to show the significance of these interspecies differences. Still, they underscore the importance of integrating rodent and primate studies to comprehensively understand TCF4 function and its implications for human disorders. Moreover, the primate-specific expression patterns of TCF4 will inform genetic and other therapeutic strategies to treat TCF4-associated disorders.

Keywords: Pitt-Hopkins syndrome; TCF4; primate; schizophrenia; subgranular zone.

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was supported by the R01NS114086, R01NS129914, and R01NS121615 to BDP, the Israeli Pitt-Hopkins Association to BDP, the Estonian Research Council PUTJD925 to HV. Microscopy was performed at the UNC Neuroscience Microscopy Core, supported in part by funding from the UNC Neuroscience Center Support Grant. and Developmental Disabilities Research Center Support Grant P50 HD103573.